Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 71

Sort by

Sort Order Select

Journal Articles

Sex-specific differences in genetic and nongenetic determinants of mean platelet volume: results from the Gutenberg Health Study

Marina Panova-Noeva, Andreas Schulz, M. Iris Hermanns, Vera Grossmann, Evgenia Pefani, Henri M. H. Spronk, Dagmar Laubert-Reh, Harald Binder, Manfred Beutel, Norbert Pfeiffer, Stefan Blankenberg, Tanja Zeller, Thomas Münzel, Karl J. Lackner, Hugo ten Cate, Philipp S. Wild

Blood (2016) 127 (2): 251–259.

https://doi.org/10.1182/blood-2015-07-660308

Published: 2016

Includes: Supplemental data

Journal Articles

Two Novel Distinct Subtypes of Myeloid Neoplasms Molecularly Associated with Histone H3K36 Methylations

Blood (2015) 126 (23): 2841.

https://doi.org/10.1182/blood.V126.23.2841.2841

Published: 2015

Journal Articles

Landscape of DNA Methylation and Genetic Profiles in 291 Patients with Myelodysplastic Syndromes

Blood (2015) 126 (23): 5205.

https://doi.org/10.1182/blood.V126.23.5205.5205

Published: 2015

Journal Articles

ZRSR2 Mutations Cause Dysregulated RNA Splicing in MDS

Vikas Madan, PhD, Deepika Kanojia, PhD, Li Jia, Ryoko Okamoto, PhD, Aiko Sato-Otsubo, Alexander Kohlmann, PhD, Masashi Sanada, MD PhD, Vera Grossmann, Janani Sundaresan, Yuichi Shiraishi, PhD, Satoru Miyano, PhD, Felicitas Thol, MD, Arnold Ganser, Henry Yang, PhD, Torsten Haferlach, Seishi Ogawa, MD PhD, H. Phillip Koeffler

Blood (2014) 124 (21): 4609.

https://doi.org/10.1182/blood.V124.21.4609.4609

Published: 2014

Journal Articles

Deep-Sequencing Of The Molecular Landscape In Burkitt Lymphoma/Leukemia

Alexander Kohlmann, PhD, Andreas Roller, PhD, Jennifer Kienast, Sabine Denzel, PhD, Vera Grossmann, PhD, Niroshan Nadarajah, MSc, Tamara Alpermann, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 2998.

https://doi.org/10.1182/blood.V122.21.2998.2998

Published: 2013

Journal Articles

Mutational Complexity Is Related To Disease Severity In Systemic Mastocytosis

Blood (2013) 122 (21): 4094.

https://doi.org/10.1182/blood.V122.21.4094.4094

Published: 2013

Journal Articles

Myelodysplastic Syndromes (MDS) With 20q Deletion Show a High Frequency Of Associated Cytogenetic and Molecular Lesions With An Association To U2AF1 , SRSF2 , and Prognostically Adverse ASXL1 Mutations

Ulrike Bacher, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD, Melanie Zenger, Manja Meggendorfer, PhD, Andreas Roller, PhD, Vera Grossmann, PhD, Maria Theresa Krauth, MD, Sabine Jeromin, PhD, Tamara Alpermann, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 657.

https://doi.org/10.1182/blood.V122.21.657.657

Published: 2013

Journal Articles

Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes

Blood (2013) 122 (21): 521.

https://doi.org/10.1182/blood.V122.21.521.521

Published: 2013

Journal Articles

EZH2 mutations are frequent and represent an early event in follicular lymphoma

Blood (2013) 122 (18): 3165–3168.

https://doi.org/10.1182/blood-2013-04-496893

Published: 2013

Includes: Supplemental data

Journal Articles

Comprehensive mutational profiling in advanced systemic mastocytosis

Blood (2013) 122 (14): 2460–2466.

https://doi.org/10.1182/blood-2013-04-496448

Published: 2013

Includes: Supplemental data

Journal Articles

Analysis of 12 Genes in 268 Cases with CMML Identifies ASXL1 Mutations As the Most Important Genetic Alteration Associated with Adverse Outcome

Susanne Schnittger, PhD, Manja Meggendorfer, PhD, Vera Grossmann, MSc, Tamara Alpermann, Christiane Eder, PhD, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2012) 120 (21): 3491.

https://doi.org/10.1182/blood.V120.21.3491.3491

Published: 2012

Journal Articles

Acute Lymphoblastic Leukemia (ALL) with Low-Hypodiploid/near Triploid Karyotype Is a Specific Clinical Entity with Poor Outcome

Claudia Haferlach, MD, Melanie Zenger, Vera Grossmann, MSc, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2012) 120 (21): 1429.

https://doi.org/10.1182/blood.V120.21.1429.1429

Published: 2012

Journal Articles

Acquisition of TP53 Mutations in Chronic Lymphocytic Leukemia (CLL) Patients During the Course of Disease Is Associated with an Unmutated IGHV Status and Mutations in XPO1 and SF3B1

Vera Grossmann, MSc, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Sandra Weissmann, PhD, Frank Dicker, PhD, Sabine Jeromin, PhD, Lucia Boeck, Tamara Alpermann, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2012) 120 (21): 1768.

https://doi.org/10.1182/blood.V120.21.1768.1768

Published: 2012

Journal Articles

Recurrent ATM and BIRC3 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) and Deletion 11q22-q23

Vera Grossmann, MSc, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Sandra Weissmann, PhD, Sabine Jeromin, PhD, Jennifer Kienast, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2012) 120 (21): 1771.

https://doi.org/10.1182/blood.V120.21.1771.1771

Published: 2012

Journal Articles

Acute Erythroid Leukemia (AEL) Can Be Separated Into Distinct Prognostic Subsets Based On Cytogenetic and Molecular Genetic Characteristics

Vera Grossmann, MSc, Claudia Haferlach, MD, Susanne Schnittger, PhD, Ulrike Bacher, MD, Franziska Poetzinger, Sandra Weissmann, PhD, Andreas Roller, PhD, Christiane Eder, PhD, Annette Fasan, PhD, Melanie Zenger, Marita Staller, Wolfgang Kern, MD, Alexander Kohlmann, PhD, Torsten Haferlach, MD

Blood (2012) 120 (21): 1394.

https://doi.org/10.1182/blood.V120.21.1394.1394

Published: 2012

Journal Articles

Analysis of SF3B1 in a Large Cohort of Refractory Anemia with Ring Sideroblasts with/without Marked Thrombocytosis (RARS-T/RARS) in an European Multicentre Study Reveals a High Incidence (86.3%) of Mutations and an Independent Favorable Association with Outcome

Susanne Schnittger, PhD, Ulrich Germing, Julien Broseus, Vera Grossmann, MSc, Tamara Alpermann, Lourdes Florensa Brichs, MD, Eric Lippert, PhD, Francois Liferman, MD, Sabine Jeromin, PhD, Torsten Haferlach, MD, Francois Girodon, MD, PhD

Blood (2012) 120 (21): 3798.

https://doi.org/10.1182/blood.V120.21.3798.3798

Published: 2012

Journal Articles

The Impact of Homozygosity and Size of the 13q Deletion in Patients with CLL

Claudia Haferlach, MD, Melanie Zenger, Vera Grossmann, MSc, Frank Dicker, PhD, Sabine Jeromin, PhD, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2012) 120 (21): 3892.

https://doi.org/10.1182/blood.V120.21.3892.3892

Published: 2012

Journal Articles

SF3B1 Mutations Are Detectable in 48.9% of Acute Myeloid Leukemia with Normal Karyotype (AML-NK) and ≥15% Ring Sideroblasts and Are Closely Related to FLT3 -ITD and RUNX1 Mutations

Sabine Jeromin, PhD, Ulrike Bacher, MD, Katharina Bayer, Frank Dicker, PhD, Christiane Eder, PhD, Annette Fasan, PhD, Vera Grossmann, MSc, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2012) 120 (21): 406.

https://doi.org/10.1182/blood.V120.21.406.406

Published: 2012

Journal Articles

Mixed Phenotype Acute Leukemia, T/Myeloid, NOS (MPAL-TM) Has a High DNMT3A Mutation Frequency and Carries Further Genetic Features of Both AML and T-ALL: Results of a Comprehensive Next-Generation Sequencing Study Analyzing 32 Genes

Wolfgang Kern, MD, Vera Grossmann, MSc, Andreas Roller, PhD, Sandra Weissmann, PhD, Tamara Alpermann, Ulrike Schoeck, MSc, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Alexander Kohlmann, PhD

Blood (2012) 120 (21): 403.

https://doi.org/10.1182/blood.V120.21.403.403

Published: 2012

Journal Articles

Comparison of Mutation Patterns Between Diagnosis and Relapse in 444 Patients with Acute Myeloid Leukemia Shows High Variability of Stability and Influence On Time to Relapse

Susanne Schnittger, PhD, Tamara Alpermann, Niroshan Nadarajah, MSc, Vera Grossmann, MSc, Christiane Eder, PhD, Alexander Kohlmann, PhD, Annette Fasan, PhD, Frank Dicker, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2012) 120 (21): 408.

https://doi.org/10.1182/blood.V120.21.408.408

Published: 2012

NARROW

Sex-specific differences in genetic and nongenetic determinants of mean platelet volume: results from the Gutenberg Health Study

Two Novel Distinct Subtypes of Myeloid Neoplasms Molecularly Associated with Histone H3K36 Methylations

Landscape of DNA Methylation and Genetic Profiles in 291 Patients with Myelodysplastic Syndromes

ZRSR2 Mutations Cause Dysregulated RNA Splicing in MDS

Deep-Sequencing Of The Molecular Landscape In Burkitt Lymphoma/Leukemia

Mutational Complexity Is Related To Disease Severity In Systemic Mastocytosis

Myelodysplastic Syndromes (MDS) With 20q Deletion Show a High Frequency Of Associated Cytogenetic and Molecular Lesions With An Association To U2AF1 , SRSF2 , and Prognostically Adverse ASXL1 Mutations

Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes

EZH2 mutations are frequent and represent an early event in follicular lymphoma

Comprehensive mutational profiling in advanced systemic mastocytosis

Analysis of 12 Genes in 268 Cases with CMML Identifies ASXL1 Mutations As the Most Important Genetic Alteration Associated with Adverse Outcome

Acute Lymphoblastic Leukemia (ALL) with Low-Hypodiploid/near Triploid Karyotype Is a Specific Clinical Entity with Poor Outcome

Acquisition of TP53 Mutations in Chronic Lymphocytic Leukemia (CLL) Patients During the Course of Disease Is Associated with an Unmutated IGHV Status and Mutations in XPO1 and SF3B1

Recurrent ATM and BIRC3 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) and Deletion 11q22-q23

Acute Erythroid Leukemia (AEL) Can Be Separated Into Distinct Prognostic Subsets Based On Cytogenetic and Molecular Genetic Characteristics

Analysis of SF3B1 in a Large Cohort of Refractory Anemia with Ring Sideroblasts with/without Marked Thrombocytosis (RARS-T/RARS) in an European Multicentre Study Reveals a High Incidence (86.3%) of Mutations and an Independent Favorable Association with Outcome

The Impact of Homozygosity and Size of the 13q Deletion in Patients with CLL

SF3B1 Mutations Are Detectable in 48.9% of Acute Myeloid Leukemia with Normal Karyotype (AML-NK) and ≥15% Ring Sideroblasts and Are Closely Related to FLT3 -ITD and RUNX1 Mutations

Mixed Phenotype Acute Leukemia, T/Myeloid, NOS (MPAL-TM) Has a High DNMT3A Mutation Frequency and Carries Further Genetic Features of Both AML and T-ALL: Results of a Comprehensive Next-Generation Sequencing Study Analyzing 32 Genes

Comparison of Mutation Patterns Between Diagnosis and Relapse in 444 Patients with Acute Myeloid Leukemia Shows High Variability of Stability and Influence On Time to Relapse

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only